Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir R Aref

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
ACS Pharmacology & Translational Science|December 14, 2023
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing ToolsAkbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 23, 2012
Screening therapeutic EMT blocking agents in a three-dimensional microenvironmentAmir R Aref, Ruby Yun-Ju Huang, Weimiao Yu, et al.
Expert Opinion on Drug Delivery|January 24, 2015
Carbon nanotubes part II: a remarkable carrier for drug and gene deliveryMahdi Karimi, Navid Solati, Amir Ghasemi, et al.
Expert Opinion on Drug Delivery|January 21, 2015
Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicleMahdi Karimi, Navid Solati, Mohammad Amiri, et al.
ACS Applied Bio Materials|January 10, 2022
Polyethylenimine-Functionalized Carbon Dots for Delivery of CRISPR/Cas9 ComplexesIman Hashemzadeh, Akbar Hasanzadeh, Fatemeh Radmanesh, et al.
Journal of Cellular Physiology|April 19, 2022
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivityMahmood K Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockadeMohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.
The Journal of Clinical Investigation|November 4, 2014
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growthThanh U Barbie, Gabriela Alexe, Amir R Aref, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
ACS Pharmacology & Translational Science|December 14, 2023
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing ToolsAkbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 23, 2012
Screening therapeutic EMT blocking agents in a three-dimensional microenvironmentAmir R Aref, Ruby Yun-Ju Huang, Weimiao Yu, et al.
Expert Opinion on Drug Delivery|January 24, 2015
Carbon nanotubes part II: a remarkable carrier for drug and gene deliveryMahdi Karimi, Navid Solati, Amir Ghasemi, et al.
Expert Opinion on Drug Delivery|January 21, 2015
Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicleMahdi Karimi, Navid Solati, Mohammad Amiri, et al.
ACS Applied Bio Materials|January 10, 2022
Polyethylenimine-Functionalized Carbon Dots for Delivery of CRISPR/Cas9 ComplexesIman Hashemzadeh, Akbar Hasanzadeh, Fatemeh Radmanesh, et al.
Journal of Cellular Physiology|April 19, 2022
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivityMahmood K Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockadeMohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.
The Journal of Clinical Investigation|November 4, 2014
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growthThanh U Barbie, Gabriela Alexe, Amir R Aref, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Pageof 3